Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 1;112(10):1067-1068.
doi: 10.1093/jnci/djaa092.

Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening

Steven Lehrer  1 , Peter H Rheinstein  2
Affiliations
Comment

Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening

Steven Lehrer et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relative survival (percentage) of 18 251 prostate cancer patients aged 50 years and older with distant disease vs year of diagnosis, 1998-2016. The points, top to bottom, indicate 12-month (top), 24-month, 36-month, 48-month, and 60-month (bottom) survival. For 2016, only 12-month survival was available: 2015, 12-month and 24-month; 2014, 12-month, 24-month, 36-month; 2013, 12-month, 24,-month, 36-month, 48-month. Survival increased statistically significant after 1998.
See this image and copyright information in PMC

Comment in

  • Response to Lehrer and Rheinstein.
    Fedewa SA, Ma J, Jemal A. Fedewa SA, et al. J Natl Cancer Inst. 2020 Oct 1;112(10):1069-1070. doi: 10.1093/jnci/djaa093. J Natl Cancer Inst. 2020. PMID: 32602890 Free PMC article. No abstract available.

Comment on

References

    1. Jemal A, Culp MB, Ma J, et al.Prostate cancer incidence 5 years After US Preventive Services Task Force recommendations against screening. J Natl Cancer Inst. 2020;10.1093/jnci/djaa068. - PMC - PubMed
    1. Lehrer SP. Obesity and aggressive prostate cancer. Cancer. 2020;126(10):2319–2319. - PubMed
    1. Horner MJ, Ries LAG, Krapcho M, et al.SEER Cancer Statistics Review, 1975-2006, Bethesda, MD: National Cancer Institute; 2009.
    1. Cho H, Howlader N, Mariotto AB, et al. Estimating relative survival for cancer patients from the SEER program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, NCI. 2011;2011(1):1–17.
    1. Lehrer S, Rheinstein PH.. The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age. Cancer. 2020;126(11):2718–2718. - PMC - PubMed

Substances